Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
154.54
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jun 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
69
70
Next >
JNJ Stock: The $8.9 Billion Reason Johnson & Johnson Is Up Today
April 05, 2023
JNJ stock is rising. The company announced that about 60,000 plaintiffs accepted its proposal to settle their lawsuits over its talc.
Via
InvestorPlace
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
April 05, 2023
Via
Benzinga
What's Going On With Johnson & Johnson Stock?
April 05, 2023
Johnson & Johnson (NYSE: JNJ) shares are trading higher Wednesday after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder claims.
Via
Benzinga
Better Dividend Stock: AbbVie vs. Johnson & Johnson
April 05, 2023
Both companies have a lot to offer income-seekers.
Via
The Motley Fool
J&J's on the Rise, but This Fintech Stock Is Falling Hard
April 05, 2023
Investors looked prepared for a quiet stock market open on Wednesday morning.
Via
The Motley Fool
2 Dividend Kings That Are Likely to Raise Their Payouts This Month
April 05, 2023
These companies have been increasing their dividends for a combined 126 years.
Via
The Motley Fool
This Is What Whales Are Betting On Johnson & Johnson
April 04, 2023
Via
Benzinga
Peering Into Johnson & Johnson's Recent Short Interest
April 03, 2023
Via
Benzinga
Analyst Expectations for Johnson & Johnson's Future
March 29, 2023
Via
Benzinga
Tesla, C3.ai, Johnson & Johnson, Cardlytics, Bullfrog AI Holdings: Why These 5 Stocks Are Drawing Investors' Attention Today
April 04, 2023
Via
Benzinga
Why Johnson & Johnson Stock Is Moving Higher After Hours
April 04, 2023
Johnson & Johnson (NYSE: JNJ) shares are trading higher in Tuesday's after-hours session after the company's subsidiary LTL Management re-filed for bankruptcy to resolve all talc-based baby powder...
Via
Benzinga
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
April 04, 2023
Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.
Via
The Motley Fool
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
April 04, 2023
From
Johnson & Johnson
Via
Business Wire
3 Top Healthcare Stocks to Buy for April
April 04, 2023
These pharmaceutical companies' shares are down, but their prospects are rising.
Via
The Motley Fool
3 Dow Stocks That Are Screaming Buys in April
April 04, 2023
Among the Dow Jones Industrial Average's 30 components, there are three plain-as-day bargains.
Via
The Motley Fool
9 Upcoming Dividend Increases In April 2023
April 03, 2023
April is going to be a huge month of dividend increases.
Via
Talk Markets
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?
April 03, 2023
These blue chips are down. Is it time to buy?
Via
The Motley Fool
3 Dow Stocks With Above-Average Dividends Yields to Buy in April
April 03, 2023
Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.
Via
The Motley Fool
3 Top S&P 500 Stocks Near 52-Week Lows That Look Like Bargains Now
April 03, 2023
Now's a great time to buy some shares of these highly reliable dividend-payers.
Via
The Motley Fool
3 Warren Buffett Stocks That Are No-Brainer Buys in April
April 03, 2023
Out of Berkshire Hathaway's more than four dozen holdings, there are three stocks that stand out as absolute steals right now.
Via
The Motley Fool
Could This Move by Johnson & Johnson Equal Billions for Moderna?
April 02, 2023
An RSV vaccine could be a driver of blockbuster revenue.
Via
The Motley Fool
3 Surprisingly Underrated Stocks to Buy in April
April 01, 2023
These drugmakers could deliver greater gains than many investors expect.
Via
The Motley Fool
3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio
March 31, 2023
Income-based portfolios can steady the ship when volatility spikes. Let's look at a few dividend stocks to buy right now.
Via
InvestorPlace
11 Stocks: 9 Dividend Payers 2 For Growth
March 30, 2023
Not all stocks are the same, and not all stocks serve the investor’s needs.
Via
Talk Markets
The 3 Best Stocks to Buy if You Want to Retire Early
March 30, 2023
The best stocks for early retirement strike a good balance between long-term growth and reliable security.
Via
InvestorPlace
2 Unstoppable Stocks to Buy Without Hesitation Right Now
March 30, 2023
These industry giants are going from strength to strength in a volatile market.
Via
The Motley Fool
Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review
March 29, 2023
Via
Benzinga
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
March 29, 2023
The company says it's refocusing its portfolio to focus on transformational medicines.
Via
Investor's Business Daily
Got $5,000? These 2 Blue Chip Stocks Are Near Multi-Year Lows
March 29, 2023
Both of these stocks also provide investors with attractive dividend yields of around 3%.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
March 29, 2023
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.